Literature DB >> 1176444

Human plasma R-type vitamin B12-binding proteins. I. Isolation and characterization of transcobalamin I. TRANSCOBALAMIN III. and the normal granulocyte vitamin B12-binding protein.

R L Burger, C S Mehlman, R H Allen.   

Abstract

Transcobalamin I and transcobalamin III have been purified approximately 6,000,000- and 3,000,000-fold, respectively, from normal human plasma using a purification scheme consisting of immunoadsorption, dialysis against 7.5 M guanidine HCl to remove endogenous vitamin B12, and affinity chromatography on vitamin B12-Sepharose. The two proteins were separated from each other subsequently by chromatography on DEAE-cellulose. The vitamin B12-binding protein present in granulocytes obtained from normal subjects has been purified approximately 5000-fold using affinity chromatography on vitamin B12-Sepharose as the sole purification technique. The final preparations of all three proteins were homogeneous based on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Transcobalamin I and transcobalamin III belong to the R-typed class of vitamin B12-binding proteins and are indistinguishable from each other, and from the human granulocyte, milk, and saliva R-type vitamin B12-binding proteins, when studied by immunodiffusion with rabbit anti-human milk vitamin B12-binding protein sera. The carbohydrate compositions, expressed as moles of carbohydrate per mole of vitamin B12, of transcobalamin I, transcobalamin III, and the normal granulocyte vitamin B12-binding protein, respectively, are: sialic acid, 18, 11, 11; fucose, 9, 20, 24; galactose, 41, 51, 46; mannose, 24, 22, 20; galactosamine, 2, 2, 2; and glucosamine, 46, 54, 46. The high sialic acid content of transcobalamin I appears to account for the fact that this protein elutes after transcobalamin III and the normal granulocyte vitamin B12-binding protein during chromatography on DEAE-cellulose. This observation provides support for the hypothesis that differences among the R-type vitamin B12-binding proteins are due to differences in carbohydrate content. The similarities in carbohydrate composition and other properties of transcobalamin III and the granulocyte vitamin B12-binding protein provide support for the hypothesis that human plasma transcobalamin III is derived from granulocytes. The differences observed between transcobalamin I and the normal granulocyte vitamin B12-binding protein suggest that transcobalamin I may not be derived from granulocytes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1176444

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Absorption, plasma transport, and cellular retention of cobalamin analogues in the rabbit. Evidence for the existence of multiple mechanisms that prevent the absorption and tissue dissemination of naturally occurring cobalamin analogues.

Authors:  J F Kolhouse; R H Allen
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

2.  The FUT2 secretor variant p.Trp154Ter influences serum vitamin B12 concentration via holo-haptocorrin, but not holo-transcobalamin, and is associated with haptocorrin glycosylation.

Authors:  Aneliya Velkova; Jennifer E L Diaz; Faith Pangilinan; Anne M Molloy; James L Mills; Barry Shane; Erica Sanchez; Conal Cunningham; Helene McNulty; Cheryl D Cropp; Joan E Bailey-Wilson; Alexander F Wilson; Lawrence C Brody
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

3.  The role and fate of rabbit and human transcobalamin II in the plasma transport of vitamin B12 in the rabbit.

Authors:  R J Schneider; R L Burger; C S Mehlman; R H Allen
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

Review 4.  Advances in the understanding of cobalamin assimilation and metabolism.

Authors:  Edward V Quadros
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

5.  Binding and uptake of transcobalamin II by human fibroblasts.

Authors:  P Youngdahl-Turner; L E Rosenberg; R H Allen
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

6.  Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model.

Authors:  Daniela Baldoni; Robert Waibel; Peter Bläuenstein; Filippo Galli; Violetta Iodice; Alberto Signore; Roger Schibli; Andrej Trampuz
Journal:  Mol Imaging Biol       Date:  2015-12       Impact factor: 3.488

7.  Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.

Authors:  Yi-Ying Lee; Yu-Ching Wei; Yu-Feng Tian; Ding-Ping Sun; Ming-Jen Sheu; Ching-Chieh Yang; Li-Ching Lin; Chen-Yi Lin; Chung-Hsi Hsing; Wan-Shan Li; Chien-Feng Li; Pei-Ling Hsieh; Ching-Yih Lin
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.